Klotho and follistatin gene therapy safety study
This trial tests a one-time gene therapy that may help slow or reverse signs of aging. It is for healthy adults aged 50 to 80 who are open to possible visible body changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old
- You are in generally good health
- You are willing to follow all study visits and procedures
- You are open to possible changes in your appearance or body shape
- If you are a woman who could become pregnant, you must agree to use birth control, take a pregnancy test, and sign a pregnancy waiver
- You do not have a current or past cancer, autoimmune disease, or serious kidney or liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gene therapy that may help rebuild muscle and improve blood vessel growth in people ages 35 to 75. It's designed for those with stable health conditions and no history of cancer, heart disease, blood clots, or diabetes.
This is an early-stage trial testing a new type of treatment called mRNA therapy that helps your body make missing proteins. Researchers are enrolling healthy volunteers to understand how safe and well-tolerated this approach is.
This is a research study testing whether specific gene changes are linked to fatty liver and a cholesterol pattern that raises heart risk. It may help researchers understand who is most likely to develop these conditions and why, which could guide future prevention.
This trial tests a new way to rebuild your blood stem cells to possibly slow down aging. It is for healthy adults aged 45 to 65 without serious illnesses or recent cancer.
This trial tests dietary supplements and other treatments aimed at slowing the effects of aging. It is looking for generally healthy adults who are not taking immune-altering medications or other conflicting therapies.
This study tests a potential disease-modifying treatment for people who have a specific gene mutation that causes early-onset Alzheimer's disease. The goal is to see if the treatment can delay or prevent symptoms.
Hear when a new Healthy Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.